Naratriptan Tablet, Film Coated
Product Images NDC 69452-340

5 FDA label images from Bionpharma Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Naratriptan (NDC 69452-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Molecular Structure (Naratriptan Tablets Figure 1)

Molecular Structure (Naratriptan Tablets Figure 1)
Chemical structure diagram of Naratriptan hydrochloride, showing its molecular framework including aromatic and heterocyclic rings and functional groups.*
FDA Label Image

Figure 1 (Naratriptan Tablets Figure 2)

Figure 1 (Naratriptan Tablets Figure 2)
Line graph showing the estimated probability of response over time in minutes from initial dose for placebo and Naratriptan tablets 1 mg and 2.5 mg. The y-axis represents the estimated probability of response from 0% to 100%, and the x-axis shows time in minutes from 0 to 240. Three lines depict increasing response rates over time for each group, with Naratriptan 2.5 mg showing the highest response probabilities, followed by 1 mg and placebo.*
FDA Label Image

Figure 2 (Naratriptan Tablets Figure 3)

Figure 2 (Naratriptan Tablets Figure 3)
A line graph showing the estimated probability of remedication or rescue over 25 hours from the initial dose. Three groups are compared: placebo (n=305), Naratriptan 1 mg tablets (n=491), and Naratriptan 2.5 mg tablets (n=493). The vertical axis represents the probability percentage and the horizontal axis represents time in hours.*
FDA Label Image

1 mg Carton (Naratriptan Tablets Figure 4)

1 mg Carton (Naratriptan Tablets Figure 4)
Naratriptan Tablets, USP 1 mg film-coated tablets packaging label from Bionpharma Inc. The label states that each film-coated tablet contains 1 mg of naratriptan as the hydrochloride, with 9 unit-of-use tablets per package. Instructions include storage conditions and unit-of-use blister opening steps. The label features a barcode, a space for an affixed pharmacy label, and NDC 69452-340-72.*
FDA Label Image

2.5 mg Carton (Naratriptan Tablets Figure 5)

2.5 mg Carton (Naratriptan Tablets Figure 5)
Naratriptan Tablets, USP 2.5 mg film-coated tablets in unit-of-use packaging from Bionpharma Inc. The label indicates 9 tablets per package with instructions to dispense a patient information leaflet. Storage and blister opening directions are detailed, with manufacture in India. The label includes NDC 69452-341-72 and spaces for pharmacy label and lot/expiration info.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.